Описание вещества Триметазидин (Trimethazidinum): инструкция

www.rlsnet.ru

Триметазидин (Trimetazidine): инструкция, применение и формула. Содержание. Структурная формула; Латинское название вещества Триметазидин ...

Триметазидин — Википедия

ru.wikipedia.org

Триметазидин (МНН триметазидина дигидрохлорид) — антиангинальный препарат. ... Триметазидин (Trimetazidine). Химическое соединение.

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD ...

www.rpcardio.com

Aim. To study effects of trimetazidine on the left ventricular diastolic dysfunction in patients with combination of ischemic heart disease (IHD) and arterial ...

Trimetazidine, but not isosorbide dinitrate, improves ...

elibrary.ru

Background: Several small randomized controlled trials showed that trimetazidine (TMZ) improves cardiac function parameters, exercise tolerance, quality of life ...

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN ...

www.rpcardio.com

Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine.

Beneficial effects of trimetazidine modified release therapy in post ...

elibrary.ru

The aim of our study was to investigate the effects of trimetazidine modified release (TMZ MR) in post myocardial infarction patients with multivessel disease  ...

ТРИМЕТАЗИДИН таблетки - инструкция по применению, отзывы ...

health.mail.ru

TRIMETAZIDINE. Другие лекарственные формы: капсулы. Цена на ТРИМЕТАЗИДИН, таблетки в аптеках (Москва). 123Р. Купить. По этой цене — только ...

ТРИМЕТАЗИДИН (Trimetazidine)

ill.ru

ТРИМЕТАЗИДИН (Trimetazidine). Область применения: Профилактика приступов стенокардии; ишемическая болезнь сердца; хориоретинальные ...

Прекондиционирование миокарда триметазидином при ...

medi.ru

Trimetazidine used in patients with coronary heart disease during coronary ... Key words: pharmacological conditioning, trimetazidine, myocardial protection.

Сравнительное изучение эффективности и переносимости ...

www.lvrach.ru

The study of therapeutic effectiveness and tolerance of two trimetazidine preparations with patients with stable angina has shown that clinical effectiveness of ...

Trimetazidine - Wikipedia

en.wikipedia.org

Trimetazidine is a drug for angina pectoris sold under the brand name Vastarel MR. Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France).

Trimetazidine - Drugs.com

www.drugs.com

Trimetazidine is a medicine available in a number of countries worldwide. A list of US medications equivalent to Trimetazidine is available on the Drugs.com website.

Trimetazidine: The Heart Drug You've Never Heard Of - Life Extension

www.lifeextension.com

This drug is called as trimetazidine (TMZ). Also marketed as Vastarel MR in Europe, it modulates mitochondrial metabolism to energize and revive compromised heart tissue.

Assessment Report

www.ema.europa.eu

The CHMP was requested to give its opinion on whether the marketing authorisations for trimetazidine containing medicinal products should be maintained, varied, suspended or withdrawn.

Trimetazidine : Wikis (The Full Wiki)

www.thefullwiki.org

Related topics. Trimetazidine: Wikis. Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article!

Trimetazidine

en.academic.ru

Trimetazidine is a drug for angina pectoris, sometimes referred to by the brand name Vastarel MR. Each tablet contains 35 mg of trimetazidine.Trimetazidine is an anti-ischemic (anti-anginal)...

Trimetazidine - DrugBank

www.drugbank.ca

Trimetazidine is a drug for angina pectoris sold under the brand name Vastarel MR. Trimetazidine is described as the first cytoprotective...

Trimetazidine Side Effects

www.patientsville.com

Trimetazidine Side Effect Report#8077912-3 Injection Site Haematoma.

Anti-ischemic cardioprotection

www.heartandmetabolism.com

Anti-ischemic cardioprotection with trimetazidine

Trimetazidine: a metabolic agent for

www.researchgate.net

Safety and efficacy of trimetazidine MR promise to expand the role of metabolic agents for the treatment of ischaemic heart disease.

Поиск реализован с помощью Yandex XML и Google Custom Search API